SCHEMBL6737148

SCHEMBL6737148

[CH2]Cc1c(N)cccc1[N+](=O)[O-]

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
PDE7A Q13946 1/20 0.46
TDP1 Q9NUW8 6/20 0.45
GPR35 Q9HC97 2/20 0.44
TSHR P16473 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
GAA P10253 1/20 0.40
S100A4 P26447 1/20 0.39
CTSD P07339 1/20 0.39
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5781293 0.86 TDP1 (0.54) SMN1; SMN2TDP1GPR35TSHRALDH1A1
SCHEMBL1374438 0.85 GPR35 (0.48) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL3599344 0.83 SMN1; SMN2 (0.47) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL6741088 0.83 SMN1; SMN2 (0.47) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL11032366 0.81 TSHR (0.52) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL1668133 0.81 TDP1 (0.48) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL11668086 0.81 SMN1; SMN2 (0.42) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL3393735 0.79 GPR35 (0.46) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL7166893 0.79 TDP1 (0.46) SMN1; SMN2PDE7ATDP1GPR35TSHR
SCHEMBL4692661 0.77 PDE7A (0.46) SMN1; SMN2PDE7ATDP1GPR35TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed